(NaturalNews) The FDA approved Zevaskyn, the first cell-based gene therapy for recessive dystrophic epidermolysis bullosa (RDEB), a rare and painful genetic dis…
FDA approves first cell-based gene therapy for rare, devastating skin disorder â but it comes with a huge price tag

Estimated read time
1 min read